ADAM C DERBYSHIRE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ADAM C DERBYSHIRE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ADAM C DERBYSHIRE. ADAM C DERBYSHIRE is EVP Finance/CFO in SALIX PHARMACEUTICALS LTD ($SLXP).
Latest Insider Trading Transactions of ADAM C DERBYSHIRE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26 2014 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Grant | A | 158.30 | 20,763 | 3,286,783 | 218,463 | 197.7 K to 218.5 K (+10.50 %) |
| Jul 03 2014 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 123.35 | 2,458 | 303,194 | 197,700 | 200.2 K to 197.7 K (-1.23 %) |
| Apr 21 2014 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Grant | A | 100.66 | 20,763 | 2,090,004 | 200,158 | 179.4 K to 200.2 K (+11.57 %) |
| Jan 13 2014 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 18.87 | 30,001 | 566,218 | 0 | |
| Jan 13 2014 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 91.44 | 27,601 | 2,523,835 | 179,395 | 207 K to 179.4 K (-13.33 %) |
| Jan 13 2014 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 91.95 | 2,400 | 220,680 | 206,996 | 209.4 K to 207 K (-1.15 %) |
| Jan 13 2014 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 18.87 | 30,001 | 566,218 | 209,396 | 179.4 K to 209.4 K (+16.72 %) |
| Jan 06 2014 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 89.94 | 9,135 | 821,602 | 179,395 | 188.5 K to 179.4 K (-4.85 %) |
| Jul 03 2013 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 66.15 | 6,362 | 420,846 | 188,530 | 194.9 K to 188.5 K (-3.26 %) |
| Apr 22 2013 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Grant | A | 48.70 | 24,421 | 1,189,303 | 194,892 | 170.5 K to 194.9 K (+14.33 %) |
| Jan 04 2013 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 40.47 | 6,130 | 248,081 | 170,471 | 176.6 K to 170.5 K (-3.47 %) |
| Dec 28 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 8.00 | 90,000 | 720,000 | 0 | |
| Dec 28 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 41.44 | 60,000 | 2,486,382 | 176,601 | 236.6 K to 176.6 K (-25.36 %) |
| Dec 28 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 8.00 | 90,000 | 720,000 | 236,601 | 146.6 K to 236.6 K (+61.39 %) |
| Jul 05 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 54.44 | 6,248 | 340,141 | 146,601 | 152.8 K to 146.6 K (-4.09 %) |
| Apr 27 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Grant | A | 0.00 | 21,711 | 0 | 152,849 | 131.1 K to 152.8 K (+16.56 %) |
| Mar 01 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 4.07 | 12,600 | 51,239 | 0 | |
| Mar 01 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 50.09 | 12,600 | 631,134 | 131,138 | 143.7 K to 131.1 K (-8.77 %) |
| Mar 01 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 4.07 | 12,600 | 51,239 | 143,738 | 131.1 K to 143.7 K (+9.61 %) |
| Feb 15 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 4.07 | 12,891 | 52,423 | 12,600 | |
| Feb 15 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 50.00 | 12,891 | 644,550 | 131,138 | 144 K to 131.1 K (-8.95 %) |
| Feb 15 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 4.07 | 12,891 | 52,423 | 144,029 | 131.1 K to 144 K (+9.83 %) |
| Feb 07 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 4.07 | 776 | 3,156 | 25,491 | |
| Feb 07 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 50.00 | 776 | 38,800 | 131,138 | 131.9 K to 131.1 K (-0.59 %) |
| Feb 07 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 4.07 | 776 | 3,156 | 131,914 | 131.1 K to 131.9 K (+0.59 %) |
| Jan 19 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 4.07 | 375 | 1,525 | 26,267 | |
| Jan 19 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Option Exercise | M | 4.07 | 3,358 | 13,656 | 26,642 | |
| Jan 19 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 4.07 | 375 | 1,525 | 131,138 | 131.5 K to 131.1 K (-0.29 %) |
| Jan 19 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 4.07 | 375 | 1,525 | 131,513 | 131.1 K to 131.5 K (+0.29 %) |
| Jan 19 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Sell | S | 50.06 | 3,358 | 168,098 | 131,138 | 134.5 K to 131.1 K (-2.50 %) |
| Jan 19 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Buy | M | 4.07 | 3,358 | 13,656 | 134,496 | 131.1 K to 134.5 K (+2.56 %) |
| Jan 05 2012 | SLXP | SALIX PHARMACEUTIC ... | DERBYSHIRE ADAM C | EVP Finance/CFO | Payment of Exercise | F | 47.85 | 2,852 | 136,468 | 131,138 | 134 K to 131.1 K (-2.13 %) |
Page: 1